SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN) today reported its financial results for the first quarter ended March 31, 2009. In the first quarter of 2009, the company’s net loss declined to $18.1 million, or $0.26 per share, from $40.9 million, or $0.60 per share, for the prior year’s first quarter. The decreased loss primarily resulted from higher revenues as well as lower research and development expenses.
